Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Medical Oncology
•
Hematology
•
Iron Homeostasis
How would you medically manage a patient with chronic GI bleed from AVMs who needs weekly transfusion and IV iron with otherwise repeatedly negative GI work up?
Any indication of octreotide in these settings?
Related Questions
What is the indication for phlebotomy in compound heterozygous hemochromatosis?
Does evidence support extending the duration of intravenous iron dextran (INFeD) infusion in pregnant patients?
How would you treat an elderly newly diagnosed tDLBCL that has previously seen R-CHOP and Bendamustine-Obinutuzumab prior to the transformative event?
Which patients with relapsed/refractory NHL are appropriate for pre-CAR-T bridging radiation therapy?
Is there an optimal salvage radiation dose for relapsed post-CART disease?
How do you modify Daratumumab-RVD relative to the protocols used in trials when used as a first-line agent to transplant-eligible patients with myeloma?
How do you approach autologous stem cell transplant in T-cell lymphomas/PTCL after induction chemotherapy with achievement of CR1?
How would you follow a patient with polycythemia without secondary causes on evaluation who was found to have a normal erythropoietin level and JAK2 V617F mutation but VAF < 2%?
Would you recommend holding momelotinib before surgery?
What is your strategy for optimizing hydroxyurea dosage in patients with symptomatic sickle cell disease, particularly for genotypes HbSS and HbS/Beta thal?